Medical specialists from Israel tagged as investigators in clinical trials studying Multiple Myeloma

Total 24 results

Amos Cohen
Seen in:
- Petah Tikva, Rabin Medical Center (Beilinson Hospital)
Trials:
- NCT04414475 (Principal Investigator)
Conditions:
- Multiple Myeloma, Refractory
Amos M Cohen
Seen in:
- Petach Tikva, GSK Investigational Site
Trials:
- NCT04484623 (Principal Investigator)
Conditions:
- Multiple Myeloma
Anatoly Nemets, MD
Seen in:
- Ashkelon, Barzilai Medical Center
Trials:
- NCT04414475 (Principal Investigator)
Conditions:
- Multiple Myeloma, Refractory
Arnon Nagler, MD
Seen in:
- Tel-Hashomer, Chaim Sheba Medical Center
Trials:
- NCT02507479 (Principal Investigator)
- NCT02488382 (Principal Investigator)
- NCT01991301 (Principal Investigator)
Conditions:
Avichai Shimoni, MD
Seen in:
- Tel-Hashomer, Chaim Sheba Medical Center
Trials:
- NCT02507479 (Sub-Investigator)
Conditions:
Celia Suriu
Seen in:
- Nahariya, GSK Investigational Site
Trials:
- NCT04484623 (Principal Investigator)
Conditions:
- Multiple Myeloma
Chezi Ganzel
Seen in:
- Jerusalem, Shaare Zedek Medical Center
Trials:
- NCT04414475 (Principal Investigator)
Conditions:
- Multiple Myeloma, Refractory
Evgeni Chubar
Seen in:
- Afula, Emek Medical Center
Trials:
- NCT04414475 (Principal Investigator)
Conditions:
- Multiple Myeloma, Refractory
Hila Magen
Seen in:
- Ramat Gan, GSK Investigational Site
- Ramat Gan, The Chaim Sheba Medical Center at Tel HaShomer
- Tel Aviv, Ramat Gan, The Chaim Sheba Medical Center
Trials:
- NCT03215030 (Principal Investigator)
- NCT04484623 (Principal Investigator)
- NCT04414475 (Principal Investigator)
Conditions:
- Multiple Myeloma;
- Multiple Myeloma, Refractory
Inna Tsoran-Rosenthal
Seen in:
- Haifa, GSK Investigational Site
Trials:
- NCT04484623 (Principal Investigator)
Conditions:
- Multiple Myeloma
Irit Avivi
Seen in:
- Tel Aviv, GSK Investigational Site
Trials:
- NCT04484623 (Principal Investigator)
Conditions:
- Multiple Myeloma
Julia Vaxman
Seen in:
- Petach Tikva, GSK Investigational Site
- Petah Tikva, Rabin Medical Center, Beilinson Campus
Trials:
- NCT04126200 (Principal Investigator)
- NCT05556616 (Principal Investigator)
Conditions:
- Multiple Myeloma
Merav Leiba
Seen in:
- Ashdod, Assuta Ashdod Medical Center
- Ashdod, GSK Investigational Site
- HaDarom, Ashdod, Assuta Ashdod University Hospital
Trials:
- NCT05556616 (Principal Investigator)
- NCT04484623 (Principal Investigator)
- NCT02290951 (Principal Investigator)
- NCT04414475 (Principal Investigator)
Conditions:
Moshe Etzion Gatt
Seen in:
- Jerusalem, GSK Investigational Site
Trials:
- NCT04484623 (Principal Investigator)
Conditions:
- Multiple Myeloma
Moshe Gatt
Seen in:
- Jerusalem, Hadassah Medical Center
Trials:
- NCT03215030 (Principal Investigator)
- NCT04414475 (Principal Investigator)
Conditions:
- Multiple Myeloma;
- Multiple Myeloma, Refractory
Moshe Yeshurun, M.D.
Seen in:
- Petah-Tiqva, BMT Unit, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital
- Petah-Tiqva, BMT unit, Rabin Medical Center, Beilinson Hospital
Trials:
- NCT01596192 (Sub-Investigator)
- NCT01555359 (Sub-Investigator)
Conditions:
Noa Lavi
Seen in:
- Haifa, GSK Investigational Site
- Haifa, Rambam Health Care Campus
- Haifa, Rambam Health Care Campus (RHCC) - Meyer Children's Hospital - Pediatric Diabetes & Obesity Clinic
Trials:
- NCT04126200 (Principal Investigator)
- NCT05556616 (Principal Investigator)
- NCT04414475 (Principal Investigator)
Conditions:
- Multiple Myeloma;
- Multiple Myeloma, Refractory
Ory Rouvio
Seen in:
- Beer Sheva Negev, Be'er Sheva, Soroka University Medical Center (Sumc)
- Beer-Sheva, GSK Investigational Site
Trials:
- NCT05556616 (Principal Investigator)
- NCT04484623 (Principal Investigator)
Conditions:
- Multiple Myeloma
Osnat Jarchowsky, MD
Seen in:
- Kfar Saba, Meir Medical Center
Trials:
- NCT04414475 (Principal Investigator)
Conditions:
- Multiple Myeloma, Refractory
Osnat Jarchowsky Dolberg
Seen in:
- Kfar Saba, GSK Investigational Site
Trials:
- NCT04484623 (Principal Investigator)
Conditions:
- Multiple Myeloma
Ron Ram, M.D.
Seen in:
- Petah-Tiqva, BMT Unit, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital
- Petah-Tiqva, BMT unit, Rabin Medical Center, Beilinson Hospital
Trials:
- NCT01596192 (Principal Investigator)
- NCT01555359 (Principal Investigator)
Conditions:
Rosa Ruchlemer
Seen in:
- Jerusalem, GSK Investigational Site
Trials:
- NCT04484623 (Principal Investigator)
Conditions:
- Multiple Myeloma
Tamar Tadmor
Seen in:
- Haifa, Bnai Zion Medical Center
- Haifa, Bnai-Zion Medical Center
Trials:
- NCT04662255 (Principal Investigator)
- NCT04797780 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04414475 (Principal Investigator)
Conditions:
Yael Cohen
Seen in:
- Tel Aviv, GSK Investigational Site
- Tel Aviv, Tel Aviv Sourasky Medical Center
Trials:
- NCT03215030 (Principal Investigator)
- NCT04126200 (Principal Investigator)
- NCT04414475 (Principal Investigator)
Conditions:
- Multiple Myeloma;
- Multiple Myeloma, Refractory

Clinical Trials on Multiple Myeloma

Lawson Health Research Institute
The Ottawa Hospital; Hamilton Health Sciences Corporation; Dalhousie University; Niagara Health System

Active, not recruiting

Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma (RithMM)

Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma Stage I | Multiple Myeloma Progression | Multiple Myeloma Stage II | Multiple Myeloma Stage III

Canada
National Cancer Institute (NCI)

Active, not recruiting

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Smoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple Myeloma

United States
Fred Hutchinson Cancer Research Center/University...
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
Mayo Clinic

Completed

Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant

Multiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Terminated

Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Relapsed Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
City of Hope Medical Center

Completed

Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
University of Washington
National Cancer Institute (NCI)

Terminated

Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States

Medical specialists from Israel tagged as investigators in clinical trials studying Multiple Myeloma

Clinical Trials on Multiple Myeloma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations